Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05620043 · ClinicalTrials.gov registry record · NA
Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05620043 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 21 participants.
The verdict
NCT05620043, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To compare gene expression stimulated by a semi-permanent filler and a biostimulator via punch biopsy
Interventions
- DEVICE Sculptra
- DEVICE Radiesse Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-09-28 |
| Est. Completion | 2023-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05620043
The ClinicalTrials.gov registry entry for NCT05620043 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sculptra is the first listed.
NCT05620043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05620043 about?
NCT05620043 is a clinical study titled "Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler". To compare gene expression stimulated by a semi-permanent filler and a biostimulator via punch biopsy
What is the current status of trial NCT05620043?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2022-09-28. Estimated completion is 2023-11-06.
What interventions are being tested in trial NCT05620043?
The interventions under investigation include: Sculptra (DEVICE), Radiesse Plus (DEVICE).
Who is sponsoring clinical trial NCT05620043?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.